These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38772752)

  • 1. Oral minoxidil 7.5 mg for hair loss increases heart rate with no change in blood pressure in 24 h Holter and 24 h ambulatory blood pressure monitoring.
    Sanabria BD; Perdomo YC; Miot HA; Ramos PM
    An Bras Dermatol; 2024; 99(5):734-736. PubMed ID: 38772752
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia.
    Jimenez-Cauhe J; Saceda-Corralo D; Rodrigues-Barata R; Hermosa-Gelbard A; Moreno-Arrones OM; Fernandez-Nieto D; Vaño-Galvan S
    J Am Acad Dermatol; 2019 Aug; 81(2):648-649. PubMed ID: 31054970
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to "Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: A retrospective study".
    Desai D; Nohria A; Sikora M; Mandal S; Shapiro J; Caplan AS; Garshick M; Lo Sicco K
    J Am Acad Dermatol; 2024 Jul; 91(1):e11-e12. PubMed ID: 38499178
    [No Abstract]   [Full Text] [Related]  

  • 4. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
    Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
    Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.
    Sinclair RD
    Int J Dermatol; 2018 Jan; 57(1):104-109. PubMed ID: 29231239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective cardiovascular evaluation with 24-hour Holter and 24-hour ambulatory blood pressure monitoring in men using 5-mg oral minoxidil for androgenetic alopecia.
    Sanabria BD; Palmegiani E; Seron AF; Perdomo YC; Miot HA; Müller Ramos P
    J Am Acad Dermatol; 2023 Feb; 88(2):436-437. PubMed ID: 35597386
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men.
    Tsuboi R; Arano O; Nishikawa T; Yamada H; Katsuoka K
    J Dermatol; 2009 Aug; 36(8):437-46. PubMed ID: 19691748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients.
    Hu R; Xu F; Sheng Y; Qi S; Han Y; Miao Y; Rui W; Yang Q
    Dermatol Ther; 2015; 28(5):303-8. PubMed ID: 26031764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hair loss.
    Patel JC
    Indian J Med Sci; 2000 Mar; 54(3):106-9. PubMed ID: 11227614
    [No Abstract]   [Full Text] [Related]  

  • 10. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
    Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
    Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to Desai et al, "Response to 'Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study'".
    Ong M; Lipner SR
    J Am Acad Dermatol; 2024 Jul; 91(1):e9-e10. PubMed ID: 38499180
    [No Abstract]   [Full Text] [Related]  

  • 12. Off-Label Use of Topical Minoxidil in Alopecia: A Review.
    Stoehr JR; Choi JN; Colavincenzo M; Vanderweil S
    Am J Clin Dermatol; 2019 Apr; 20(2):237-250. PubMed ID: 30604379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study].
    Piraccini B; Starace M; Alessandrini A; Guarrera M; Fiorucci MC; Lorenzi S
    G Ital Dermatol Venereol; 2011 Dec; 146(6 Suppl 1):1-8. PubMed ID: 22189834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
    Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
    J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapy.
    Beach RA
    Dermatol Ther; 2018 Nov; 31(6):e12707. PubMed ID: 30246901
    [No Abstract]   [Full Text] [Related]  

  • 16. Pustular dermatosis of the scalp due to topical minoxidil 5.
    El Anzi O; Hassam B
    Pan Afr Med J; 2018; 30():83. PubMed ID: 30344867
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.
    Hoedemaker C; van Egmond S; Sinclair R
    Australas J Dermatol; 2007 Feb; 48(1):43-5. PubMed ID: 17222303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial.
    Ramos PM; Sinclair RD; Kasprzak M; Miot HA
    J Am Acad Dermatol; 2020 Jan; 82(1):252-253. PubMed ID: 31473295
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral minoxidil treatment for hair loss: A review of efficacy and safety.
    Randolph M; Tosti A
    J Am Acad Dermatol; 2021 Mar; 84(3):737-746. PubMed ID: 32622136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose oral minoxidil in women affected by traction alopecia: real-world outcomes.
    Gallo G; Rosset F; Quaglino P; Ribero S
    Int J Dermatol; 2024 Aug; 63(8):1113-1114. PubMed ID: 38736142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.